logo
Select company
Select metric
-4.89Interest Coverage
VS
Market
24
Sector
54
Industry
74
History
80
$ 13.09Close
$ 5.31 - $ 13.09 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ -145.77M$ 29.8M-4.89
3/31/2025$ -138.43M$ 19.26M-7.19
12/31/2024$ -214.44M$ 12.66M-16.94
9/30/2024$ -234.35M$ 4.61M-50.89
6/30/2024$ -235.82M$ 5.41M-43.6
3/31/2024$ -254.22M$ 6.08M-41.81
12/31/2023$ -256.78M$ 6.86M-37.42
9/30/2023$ -250.77M$ 9.81M-25.57
6/30/2023$ -260.06M$ 14.14M-18.39
3/31/2023$ -250.44M$ 19.88M-12.6
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Int. Coverage stands at 0.
  • Over the past 5 years, REGENXBIO INC's average Int. Coverage has been -22.02.
  • The median Int. Coverage for REGENXBIO INC during this period was -12.6
  • REGENXBIO INC reached its highest Int. Coverage over the past 5 years at 6.38.
  • The lowest Int. Coverage recorded by REGENXBIO INC in the same timeframe -136.5

REGENXBIO INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
CTMX : CYTOMX THERAPEUTICS INC -XNCR : XENCOR INC -3.9ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -YMAB : Y-MABS THERAPEUTICS INC -GLUE : MONTE ROSA THERAPEUTICS INC -HRTX : HERON THERAPEUTICS INC 0.62NKTR : NEKTAR THERAPEUTICS -3.62PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -52.87LXRX : LEXICON PHARMACEUTICALS INC -8.59VNDA : VANDA PHARMACEUTICALS INC -

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for REGENXBIO INC is calculated as follows: EBIT [ $ -94.37M ] / Int. Exp. [ $ 0 ]
(=) Int. Coverage [ 0 ]

RGNX - Interest Coverage, Last 5 years

-136.5

Minimum

Dec 31, 2020

6.38

Maximum

Dec 31, 2021

-22.02

Average

-12.6

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.15 with a standard deviation of 8.46.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.37K
min-25.49
max28.75
average2.15
median2.08
std8.46